Cargando…

TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells

Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity‐enhancing mutations into their B‐cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation‐induced cytidine deami...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoeler, Katia, Aufschnaiter, Andreas, Messner, Simon, Derudder, Emmanuel, Herzog, Sebastian, Villunger, Andreas, Rajewsky, Klaus, Labi, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851767/
https://www.ncbi.nlm.nih.gov/pubmed/31120187
http://dx.doi.org/10.1111/febs.14934
_version_ 1783469682172362752
author Schoeler, Katia
Aufschnaiter, Andreas
Messner, Simon
Derudder, Emmanuel
Herzog, Sebastian
Villunger, Andreas
Rajewsky, Klaus
Labi, Verena
author_facet Schoeler, Katia
Aufschnaiter, Andreas
Messner, Simon
Derudder, Emmanuel
Herzog, Sebastian
Villunger, Andreas
Rajewsky, Klaus
Labi, Verena
author_sort Schoeler, Katia
collection PubMed
description Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity‐enhancing mutations into their B‐cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation‐induced cytidine deaminase (AID). Upon germinal centre exit, B cells differentiate into antibody‐secreting plasma cells. Germinal centre maintenance and terminal fate choice require transcriptional reprogramming that associates with a substantial reconfiguration of DNA methylation patterns. Here we examine the role of ten‐eleven‐translocation (TET) proteins, enzymes that facilitate DNA demethylation and promote a permissive chromatin state by oxidizing 5‐methylcytosine, in antibody‐mediated immunity. Using a conditional gene ablation strategy, we show that TET2 and TET3 guide the transition of germinal centre B cells to antibody‐secreting plasma cells. Optimal AID expression requires TET function, and TET2 and TET3 double‐deficient germinal centre B cells show defects in CSR. However, TET2/TET3 double‐deficiency does not prevent the generation and selection of high‐affinity germinal centre B cells. Rather, combined TET2 and TET3 loss‐of‐function in germinal centre B cells favours C‐to‐T and G‐to‐A transition mutagenesis, a finding that may be of significance for understanding the aetiology of B‐cell lymphomas evolving in conditions of reduced TET function.
format Online
Article
Text
id pubmed-6851767
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68517672019-11-18 TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells Schoeler, Katia Aufschnaiter, Andreas Messner, Simon Derudder, Emmanuel Herzog, Sebastian Villunger, Andreas Rajewsky, Klaus Labi, Verena FEBS J Editor's Choice Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity‐enhancing mutations into their B‐cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation‐induced cytidine deaminase (AID). Upon germinal centre exit, B cells differentiate into antibody‐secreting plasma cells. Germinal centre maintenance and terminal fate choice require transcriptional reprogramming that associates with a substantial reconfiguration of DNA methylation patterns. Here we examine the role of ten‐eleven‐translocation (TET) proteins, enzymes that facilitate DNA demethylation and promote a permissive chromatin state by oxidizing 5‐methylcytosine, in antibody‐mediated immunity. Using a conditional gene ablation strategy, we show that TET2 and TET3 guide the transition of germinal centre B cells to antibody‐secreting plasma cells. Optimal AID expression requires TET function, and TET2 and TET3 double‐deficient germinal centre B cells show defects in CSR. However, TET2/TET3 double‐deficiency does not prevent the generation and selection of high‐affinity germinal centre B cells. Rather, combined TET2 and TET3 loss‐of‐function in germinal centre B cells favours C‐to‐T and G‐to‐A transition mutagenesis, a finding that may be of significance for understanding the aetiology of B‐cell lymphomas evolving in conditions of reduced TET function. John Wiley and Sons Inc. 2019-06-03 2019-09 /pmc/articles/PMC6851767/ /pubmed/31120187 http://dx.doi.org/10.1111/febs.14934 Text en © 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editor's Choice
Schoeler, Katia
Aufschnaiter, Andreas
Messner, Simon
Derudder, Emmanuel
Herzog, Sebastian
Villunger, Andreas
Rajewsky, Klaus
Labi, Verena
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
title TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
title_full TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
title_fullStr TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
title_full_unstemmed TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
title_short TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
title_sort tet enzymes control antibody production and shape the mutational landscape in germinal centre b cells
topic Editor's Choice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851767/
https://www.ncbi.nlm.nih.gov/pubmed/31120187
http://dx.doi.org/10.1111/febs.14934
work_keys_str_mv AT schoelerkatia tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT aufschnaiterandreas tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT messnersimon tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT derudderemmanuel tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT herzogsebastian tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT villungerandreas tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT rajewskyklaus tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells
AT labiverena tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells